Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">EHE (<i>μ</i>g/mL)</td><td class="align_center">0</td><td class="align_center">100</td><td class="align_center">200</td><td class="align_center">400</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">IC50 of erlotinib (<i>μ</i>M)</td><td class="align_center">7.44</td><td class="align_center">6.86</td><td class="align_center">4.36</td><td class="align_center">1.2</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The 50% inhibitory concentration (IC50) of erlotinib.</div>

Evidence-Based Complementary and Alternative Medicine

tab1

Table 1

Table 1: Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met 

Table 1 | Effect of Ephedra Herb on Erlotinib Resistance in c-Met-Overexpressing Non-Small-Cell Lung Cancer Cell Line, H1993, through Promotion of Endocytosis and Degradation of c-Met 